Inari Medical, Inc. (NARI) Tops Q3 EPS by 6c

Inari Medical, Inc. (NASDAQ: NARI) reported Q3 EPS of ($0.19), $0.06 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $96.2 million versus the consensus estimate of $90.79 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Target raises full-year sales forecast amid ongoing turnaround drive
• John B. Sanfilippo & Son (JBSS) Misses Q4 EPS by 59c